非肝硬化患者开放大范围解剖性肝切除的新基准值:44个国际专家中心的多中心研究
该多中心研究采用标准基准方法学,纳入44个高容量中心5年间连续接受开放大范围解剖性肝切除的患者,确定低风险非肝硬化患者的最佳可达结局基准值。8044例中2908例(36%)符合基准病例,基准截止值包括R0切除≥78%、肝功能衰竭(B/C级)≤10%、胆漏(B/C级)≤18%等,且良恶性疾病基准值显著不同。
要点
- 开放大范围解剖性肝切除基准值:R0切除≥78%,肝功能衰竭(B/C级)≤10%,胆漏(B/C级)≤18%。
- 并发症≥3级和CCI®在3个月时分别≤46%和≤9。
- 良性与恶性疾病基准值显著不同,参考值需相应调整。
核心结论
- 这些开放大范围肝切除的新基准截止值为评估其他方法(包括保留肝实质手术、腹腔镜/机器人入路及消融、放疗或新化疗方案等替代治疗)提供了有力工具。
研究设计与样本
- 采用标准基准方法学,覆盖5大洲44个高容量肝脏中心2016-2020年连续接受开放大范围解剖性肝切除的患者。
- 基准病例为在高容量中心(每年≥30例大范围肝切除)治疗的低风险非肝硬化且无显著合并症患者,每例患者最短随访1年。
- 基准值设定为所有中心中位值的第75百分位数。
主要发现
- 8044例患者中2908例(36%)符合基准(低风险)病例。
- 所有适应证的基准截止值包括R0切除≥78%、肝功能衰竭(B/C级)≤10%、胆漏(B/C级)≤18%、并发症≥3级≤46%和CCI®≤9(3个月时)。
- 良性与恶性疾病的基准值显著不同,参考值必须相应调整。
- 扩大右半肝切除(H1,4-8或H4-8)显示肝功能衰竭截止值更高,而扩大左半肝切除(H1-5,8或H2-5,8)与胆漏截止值更高相关,但与正式左半肝切除(H1-4或H2-4)相比具有更优的肿瘤学结局。
- 开放解剖性大范围切除后结论性结局评估的最短随访必须为3个月。
关键数值与推荐
- R0切除≥78%;肝功能衰竭(B/C级)≤10%;胆漏(B/C级)≤18%;并发症≥3级≤46%;CCI®≤9(3个月时)。
- 基准病例定义:低风险非肝硬化、无显著合并症、在高容量中心(≥30例大范围肝切除/年)治疗。
- 基准值设定为所有中心中位值的第75百分位数。
临床怎么用
- 这些基准截止值可用于比较不同中心、适应证、切除类型及微创手术的结局。
- 评估开放大范围肝切除结局时,良恶性疾病应使用相应调整后的参考值。
- 开放解剖性大范围切除后结论性结局评估应至少随访3个月。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aims at establishing benchmark values for best achievable outcomes following open major anatomic hepatectomy for liver tumors of all dignities. BACKGROUND: Outcomes after open major hepatectomies vary widely lacking reference values for comparisons among centers, indications, types of resections, and minimally invasive procedures. METHODS: A standard benchmark methodology was used covering consecutive patients, who underwent open major anatomic hepatectomy from 44 high-volume liver centers from 5 continents over a 5-year period (2016-2020). Benchmark cases were low-risk non-cirrhotic patients without significant comorbidities treated in high-volume centers (≥30 major liver resections/year). Benchmark values were set at the 75th percentile of median values of all centers. Minimum follow-up period was 1 year in each patient. RESULTS: Of 8044 patients, 2908 (36%) qualified as benchmark (low-risk) cases. Benchmark cutoffs for all indications include R0 resection ≥78%; liver failure (grade B/C) ≤10%; bile leak (grade B/C) ≤18%; complications ≥grade 3 and CCI ® ≤46% and ≤9 at 3 months, respectively. Benchmark values differed significantly between malignant and benign conditions so that reference values must be adjusted accordingly. Extended right hepatectomy (H1, 4-8 or H4-8) disclosed a higher cutoff for liver failure, while extended left (H1-5,8 or H2-5,8) were associated with higher cutoffs for bile leaks, but had superior oncologic outcomes, when compared to formal left hepatectomy (H1-4 or H2-4). The minimal follow-up for a conclusive outcome evaluation following open anatomic major resection must be 3 months. CONCLUSION: These new benchmark cutoffs for open major hepatectomy provide a powerful tool to convincingly evaluate other approaches including parenchymal-sparing procedures, laparoscopic/robotic approaches, and alternative treatments, such as ablation therapy, irradiation, or novel chemotherapy regimens.
引用
- Sousa Da Silva RX, Breuer E, Shankar S, et al. Novel Benchmark Values for Open Major Anatomic Liver Resection in Non-cirrhotic Patients: A Multicentric Study of 44 International Expert Centers. Ann Surg. 2023. PMID: 37465950. doi:10.1097/SLA.0000000000006012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。